Literature DB >> 3718796

Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy.

M Tanaka, H Fujiwara, T Onodera, D J Wu, Y Hamashima, C Kawai.   

Abstract

The distribution of fibrosis was studied quantitatively in the entire left ventricular wall of a transverse slice of the heart from 10 necropsy cases of hypertrophic cardiomyopathy, 10 cases of hypertensive heart disease, and 20 normal adults. The percentage area (mean (SD)) of fibrosis in the left ventricular wall in hypertrophic cardiomyopathy (10.5 (4.3)%) was significantly greater than that in hypertensive heart disease (2.6 (1.5)%) or in normal hearts (1.1 (0.5)%). In hypertrophic cardiomyopathy the percentage area of fibrosis was greater (13.1 (4.8)%) in the ventricular septum than in the left ventricular free wall (7.7 (4.2)%) whereas in hypertensive heart disease and normal hearts values in these two areas were similar. The percentage area of fibrosis in the left ventricular free wall (where myocardial fibre disarray was not extensive even in hypertrophic cardiomyopathy) was greater in hypertrophic cardiomyopathy than in hypertensive heart disease. The percentage area of fibrosis correlated with heart weight in hypertensive heart disease, but not in hypertrophic cardiomyopathy. These results suggest that widespread fibrosis in hypertrophic cardiomyopathy cannot be explained by cardiac hypertrophy alone, and that disarray and other factors are also important in pathogenesis. The increase in the percentage area of fibrosis from the outer to the inner third of the left ventricular free wall in hypertrophic cardiomyopathy and in hypertension probably reflected transmural gradients of wall stress and myocardial fibre diameter. Although fibrosis is not specific to hypertrophic cardiomyopathy, its quantification and analysis of its regional distribution provide information that is useful in investigating the pathophysiology of the disorder.

Entities:  

Mesh:

Year:  1986        PMID: 3718796      PMCID: PMC1236764          DOI: 10.1136/hrt.55.6.575

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  22 in total

1.  Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study.

Authors:  J E Sanderson; D G Gibson; D J Brown; J F Goodwin
Journal:  Br Heart J       Date:  1977-06

2.  Ultrasound study of dynamic behaviour of left ventricle in genetic asymmetric septal hypertrophy.

Authors:  F J ten Cate; P G Hugenholtz; J Roelandt
Journal:  Br Heart J       Date:  1977-06

3.  Left ventricular stress and compliance in man. With special reference to normalized ventricular function curves.

Authors:  W H Gaasch; W E Battle; A A Oboler; J S Banas; H J Levine
Journal:  Circulation       Date:  1972-04       Impact factor: 29.690

4.  Canine left ventricular intramyocardial pressures.

Authors:  J A Armour; W C Randall
Journal:  Am J Physiol       Date:  1971-06

5.  Stress distribution within the left ventricular wall approximated as a thick ellipsoidal shell.

Authors:  A Y Wong; P M Rautaharju
Journal:  Am Heart J       Date:  1968-05       Impact factor: 4.749

6.  Intramyocardial pressure. A study of its regional variations and its relationship to intraventricular pressure.

Authors:  R J Baird; R T Manktelow; P A Shah; F M Ameli
Journal:  J Thorac Cardiovasc Surg       Date:  1970-06       Impact factor: 5.209

7.  Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; W C Roberts
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

8.  Regional myocardial function in idiopathic hypertrophic subaortic stenosis. An echocardiographic study.

Authors:  M V Cohen; L B Cooperman; R Rosenblum
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

9.  Pathologic anatomy of the cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types, and endomyocardial disease with and without eosinophilia.

Authors:  W C Roberts; V J Ferrans
Journal:  Hum Pathol       Date:  1975-05       Impact factor: 3.466

10.  The reliability of the tracing-method of fine cardiac fibrosis at a magnification of x10--preliminary study for quantitative analysis of fibrosis in large tissue sections of hearts with cardiomyopathy.

Authors:  H Fujiwara; T Onodera; M Tanaka; T Fujiwara; C Kawai; Y Hamashima
Journal:  Heart Vessels       Date:  1985-08       Impact factor: 2.037

View more
  63 in total

1.  Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy.

Authors:  J J Crowley; P S Dardas; A A Harcombe; L M Shapiro
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Ventricular dysfunction in hypertrophic obstructive cardiomyopathy.

Authors:  R D Leachman
Journal:  Tex Heart Inst J       Date:  1991

3.  Extracellular matrix alterations in cardiomyopathy: The possible crucial role in the dilative form.

Authors:  V I Kapelko
Journal:  Exp Clin Cardiol       Date:  2001

4.  Evaluation of left ventricular hypertrophy in hypertensive patients with echocardiographic myocardial videodensitometry normalized by displacement.

Authors:  Xiao-Zhi Zheng; Lian-Fang Du; Hui-Ping Wang
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

Review 5.  Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar.

Authors:  Javier Díez; Arantxa González; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

6.  Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction.

Authors:  M Fassbach; B Schwartzkopff
Journal:  Z Kardiol       Date:  2005-05

7.  Can the amplitude of mitral annulus motion be used in the assessment of left ventricular systolic function in patients with left ventricular wall thickness in the upper limit of normal to mild hypertrophy?

Authors:  Kent Emilsson
Journal:  Exp Clin Cardiol       Date:  2003

8.  Cardiac MRI and CT features of inheritable and congenital conditions associated with sudden cardiac death.

Authors:  Patrick Sparrow; Naeem Merchant; Yves Provost; Deirdre Doyle; Elsie Nguyen; Narinder Paul
Journal:  Eur Radiol       Date:  2008-09-16       Impact factor: 5.315

9.  Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  James M Wilson; Rollo P Villareal; Ramesh Hariharan; Ali Massumi; Raja Muthupillai; Scott D Flamm
Journal:  Tex Heart Inst J       Date:  2002

10.  Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts.

Authors:  Shinsuke Hanatani; Yasuhiro Izumiya; Seiji Takashio; Sunao Kojima; Megumi Yamamuro; Satoshi Araki; Taku Rokutanda; Kenichi Tsujita; Eiichiro Yamamoto; Tomoko Tanaka; Shinji Tayama; Koichi Kaikita; Seiji Hokimoto; Seigo Sugiyama; Hisao Ogawa
Journal:  Heart Vessels       Date:  2013-03-23       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.